Home Cart 0 Sign in  
X

[ CAS No. 2417-72-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 2417-72-3
Chemical Structure| 2417-72-3
Chemical Structure| 2417-72-3
Structure of 2417-72-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2417-72-3 ]

Related Doc. of [ 2417-72-3 ]

Alternatived Products of [ 2417-72-3 ]

Product Details of [ 2417-72-3 ]

CAS No. :2417-72-3 MDL No. :MFCD00032453
Formula : C9H9BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :NLWBJPPMPLPZIE-UHFFFAOYSA-N
M.W : 229.07 Pubchem ID :256687
Synonyms :

Calculated chemistry of [ 2417-72-3 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.56
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.65 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.44
Log Po/w (XLOGP3) : 2.89
Log Po/w (WLOGP) : 2.22
Log Po/w (MLOGP) : 2.7
Log Po/w (SILICOS-IT) : 2.71
Consensus Log Po/w : 2.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.25
Solubility : 0.128 mg/ml ; 0.000559 mol/l
Class : Soluble
Log S (Ali) : -3.1
Solubility : 0.181 mg/ml ; 0.00079 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.74
Solubility : 0.0419 mg/ml ; 0.000183 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.64

Safety of [ 2417-72-3 ]

Signal Word:Danger Class:8,6.1
Precautionary Statements:P261-P280-P305+P351+P338-P310 UN#:2923
Hazard Statements:H311-H314-H317-H334-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 2417-72-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2417-72-3 ]
  • Downstream synthetic route of [ 2417-72-3 ]

[ 2417-72-3 ] Synthesis Path-Upstream   1~24

  • 1
  • [ 2417-72-3 ]
  • [ 34040-64-7 ]
Reference: [1] Russian Chemical Bulletin, 2014, vol. 63, # 11, p. 2564 - 2566[2] Izv. Akad. Nauk, Ser. Khim., 2014, # 11, p. 2564 - 2566,3
  • 2
  • [ 2417-72-3 ]
  • [ 19158-51-1 ]
  • [ 35066-32-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 1, p. 262 - 266
  • 3
  • [ 2417-72-3 ]
  • [ 18469-52-8 ]
Reference: [1] European Journal of Pharmacology, 2018, vol. 824, p. 78 - 88
[2] Chemistry - A European Journal, 2015, vol. 21, # 28, p. 10179 - 10184
[3] Patent: WO2006/138350, 2006, A2,
  • 4
  • [ 2417-72-3 ]
  • [ 18469-52-8 ]
  • [ 18153-53-2 ]
  • [ 70785-70-5 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 14, p. 3339 - 3345
  • 5
  • [ 2417-72-3 ]
  • [ 52787-14-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 26, p. 5219 - 5246
[2] Patent: WO2015/100363, 2015, A1,
  • 6
  • [ 2417-72-3 ]
  • [ 143-33-9 ]
  • [ 76469-88-0 ]
YieldReaction ConditionsOperation in experiment
55% at 40℃; for 1.5 h; A solution of sodium cyanide (20 g, 0.41 mol) in dimethylsulfoxide at 40° C. was treated dropwise with a solution of methyl 4-(bromomethyl)benzoate (52 g, 0.227 mol) in dimethylsulfoxide, stirred for 90 min., cooled to room temperature, quenched with saturated aqueous sodium chloride and extracted with ethyl acetate.
The combined extracts were washed with saturated aqueous sodium chloride, dried over sodium sulfate and concentrated under reduced pressure.
Purification of the concentrate via column chromatography (silica, hexanes:ethyl acetate 0-->5percent) provided methyl 4-(cyanomethyl)benzoate (55percent).
1H NMR (400 MHz, CDCl3): 8.05 (d, J=8 Hz, 2H); 7.42 (d, J=8 Hz, 2H); 3.93 (s, 3H); 3.81 (s, 2H).
[M+H] 176
55% at 40℃; for 1.5 h; Step 1:
Methyl 4-(Cyanomethyl)benzoate
A solution of sodium cyanide (20 g, 0.41 mol) in dimethylsulfoxide at 40° C. was treated dropwise with a solution of methyl 4-(bromomethyl)benzoate (52 g, 0.227 mol) in dimethylsulfoxide, stirred for 90 min., cooled to room temperature, quenched with saturated aqueous sodium chloride and extracted with ethyl acetate.
The combined extracts were washed with saturated aqueous sodium chloride, dried over sodium sulfate and concentrated under reduced pressure.
Purification of the concentrate via column chromatography (silica, hexane:ethyl acetate 0-->5percent) provided methyl 4-(cyanomethyl)benzoate (55percent).
1H NMR (400 MHz, CDCl3): 8.05 (d, J=8 Hz, 2H); 7.42 (d, J=8 Hz, 2H); 3.93 (s, 3H); 3.81 (s, 2H).
[M+H] 176
Reference: [1] Patent: US2009/23707, 2009, A1, . Location in patent: Page/Page column 26
[2] Patent: US2007/219240, 2007, A1, . Location in patent: Page/Page column 31
[3] Journal of Medicinal Chemistry, 1998, vol. 41, # 26, p. 5219 - 5246
[4] Journal of Medicinal Chemistry, 2003, vol. 46, # 3, p. 345 - 348
  • 7
  • [ 7677-24-9 ]
  • [ 2417-72-3 ]
  • [ 76469-88-0 ]
YieldReaction ConditionsOperation in experiment
68.7%
Stage #1: for 1 h;
Stage #2: at 80℃; for 1 h;
Step A: 4-Cyanomethyl-benzoic acid methyl esterTo a solution of trimethylsilylcyanide (TMSCN, 12 mL, 96 mmol), tetra-M- butylammonium fluoride (TBAF, 25 g, 96 mmol) was added portion wise over a period of 30 minutes and stirred for another 30 minutes. 4-Bromethyl benzoic acid methyl ester (20 g, 87.3 mmol) dissolved in acetonitrile (100 mL) was added drop wise over a period of 30 minutes, the reaction temperature was increased to 80 °C and stirring continued for another 30 minutes. On completion of the reaction, solvent was distilled out under reduced pressure, the crude material obtained was purified by column chromatography to give the pure title compound (10 g, Yield 68.7 percent).
Reference: [1] Patent: WO2012/117421, 2012, A1, . Location in patent: Page/Page column 37
  • 8
  • [ 2417-72-3 ]
  • [ 76469-88-0 ]
YieldReaction ConditionsOperation in experiment
58.6% for 5 h; Reflux Commercially available 4- bromomethylbenzoic acid methyl ester (5.0 g) was dissolved in methanol (40 mL) . A potassium cyanide solution (5.63 g in 8 ml water) was added dropwise over 15 min. The resulting suspension was heated to reflux for 5 h. Volatiles were removed under reduced pressure and the residue dissolved in diethylether and water. The organic layer was concentrated to a dark oil which was purified by column chromatography (5percent ethyl acetate in hexane) to give the intermediate. Yield 3.82 g, 58,6percent.. [M+H] ' - 176.3 (APCI+) . FontWeight="Bold" FontSize="10" H MP. (CHClj, 400 MHz): δ 8.05 (d, J=8.1 Hz, 1H), 7.42 (d, J=8.1 , 1H) , 3.93 (s, 3H) , 3.81 (s, 2H) .
Reference: [1] Patent: WO2015/100363, 2015, A1, . Location in patent: Page/Page column 51
[2] Angewandte Chemie - International Edition, 2010, vol. 49, # 37, p. 6633 - 6637
[3] Chemistry - A European Journal, 2012, vol. 18, # 5, p. 1383 - 1400
  • 9
  • [ 773837-37-9 ]
  • [ 2417-72-3 ]
  • [ 76469-88-0 ]
Reference: [1] Journal of Organic Chemistry, 2017, vol. 82, # 2, p. 1114 - 1126
[2] European Journal of Organic Chemistry, 2009, # 2, p. 223 - 237
[3] Patent: US4598077, 1986, A,
  • 10
  • [ 2417-72-3 ]
  • [ 151-50-8 ]
  • [ 76469-88-0 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 1999, vol. 42, # 4, p. 325 - 335
[2] Tetrahedron, 2003, vol. 59, # 46, p. 9083 - 9090
[3] European Journal of Organic Chemistry, 2002, # 6, p. 1037 - 1046
[4] Patent: US2006/173183, 2006, A1, . Location in patent: Page/Page column 118-119
  • 11
  • [ 2417-72-3 ]
  • [ 76469-88-0 ]
Reference: [1] Journal of Organic Chemistry, 1952, vol. 17, p. 1035,1040
[2] Patent: US2002/13328, 2002, A1,
[3] Patent: US6559152, 2003, B2,
  • 12
  • [ 2417-72-3 ]
  • [ 6232-11-7 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 19, p. 4418 - 4422
  • 13
  • [ 2417-72-3 ]
  • [ 71831-21-5 ]
YieldReaction ConditionsOperation in experiment
100% With diisobutylaluminium hydride In tetrahydrofuran; dichloromethane 4-Bromomethylbenzyl alcohol
To a solution of methyl 4-bromomethylbenzoate (5.73 g, 25 mmol) in dry CH2Cl2 (150 mL) cooled to -78° C. with stirring under nitrogen was added dropwise a solution of DIBAL-H (82.5 mL, 1.0 M solution in THF).
Stirring was continued for 1.5 h at -78° C., and the reaction mixture was then allowed to warm to 0° C. and quenched with H2O.
The organic layer was separated and the aqueous was extracted with CH2Cl2 (2*100 mL).
The combined organic extracts were dried (MgSO4) and evaporated to give the desired alcohol (5.0 g, 100percent) as a white solid: 1H NMR (CDCl3) δ1.84 (br, 1H), 4.49 (s, 2H), 4.67 (s, 2H), 7.33 (d, 2H, J=8.2 Hz), 7.38 (d, 2H, J=8.2 Hz).
100% With diisobutylaluminium hydride In tetrahydrofuran; dichloromethane 4-Bromomethylbenzyl Alcohol
To a solution of methyl 4-bromomethylbenzoate (5.73 g, 25 mmol) in dry CH2Cl2 (150 mL) cooled to -78° C. with stirring under nitrogen was added dropwise a solution of DIBAL-H (82.5 mL, 1.0 M solution in THF).
Stirring was continued for 1.5 h at -78° C., and the reaction mixture was then allowed to warm to 0° C. and quenched with H2O.
The organic layer was separated and the aqueous was extracted with CH2Cl2 (2*100 mL).
The combined organic extracts were dried (MgSO4) and evaporated to give the desired alcohol (5.0 g, 100percent) as a white solid: 1H NMR (CDCl3) δ 1.84 (br, 1H), 4.49 (s, 2H), 4.67 (s, 2H), 7.33 (d, 2H, J=8.2 Hz), 7.38 (d, 2H, J=8.2 Hz).
100% With diisobutylaluminium hydride In tetrahydrofuran; dichloromethane at -78℃; for 1.5 h; Inert atmosphere General procedure: 4.1.57
4-Bromomethylbenzyl alcohol (14)
To a solution of methyl 4-bromomethylbenzoate 13 (3.09 g, 13 mmol) in dry CH2Cl2 (80 mL) cooled to -78 °C with stirring under nitrogen was added dropwise a solution of DIBAL-H (47 mL, 1.0 M solution in THF).
Stirring was continued for 1.5 h at -78 °C, and the reaction mixture was then allowed to warm to 0 °C and quenched with H2O.
The organic layer was separated and the aqueous was extracted with CH2Cl2.
The combined organic extracts were dried over MgSO4 and evaporated to yield quantitatively the desired alcohol as a white solid. CAS: 71831-21-5.
90%
Stage #1: With diisobutylaluminium hydride In toluene at -20 - 35℃; for 1 h;
Stage #2: With hydrogenchloride; water In toluene at -20 - 35℃;
Example 3Preparation of intermediate (Va where n=l and R= acetyl) 4-(4-acetyl-piperazin- 1 -yl-methy lpheny Dmethano 15.5 volumes of Toluene were loaded in a glass lined vessel under N2 and cooled down to -200C +/- 2°C.In a separate vessel, 1.5 kg of methyl-4-bromo-methylbenzoate were charged portion wise while stirring under N2 at room temperature to obtain a solution (solution B).19.8 liters (3.02 eq.) of a 1 M solution DIBAL-H/Toluene under N2 were added, cooling down the solution to -200C +/- 2°C and stirring.The solution B was loaded under N2 portion wise while maintaining the temperature in the range 0-150C (< 350C) by addition over about 1 hour.Reaction was monitored by HPLC when addition was completed. The mixture was cooled down to -200C +/- 2°C under stirring.8.8 volumes (2.02 eq.) of IM acq. HCl (cooled to 5°C +/- 2°C) were added drop wise under very slow stirring and maintaining the temperature below 300C (<35°C).Stirring was stopped and phases separated at 8°C +/- 2°C. Water phase was removed.5 volumes Of H2O were then charged, maintaining the temperature at 100C +/- 2°C, very slowly stirring was done for a further 10 minutes.Stirring was stopped and phases separated at 100C +/- 2°C, then removed. Washing with water and phase separation were repeated. <n="14"/>Toluene was removed by distillation under reduced pressure maintaining solution temperature at 35°C (< 400C) to obtain a white solid with yield equal to 90percent.The above solid is dissolved in 7 volumes of dichloromethane in a vessel under N2 stirring at 25°C for about 15 minutes. In a separate vessel, 1.05 kg of N-acetyl- piperazine were dissolved in 3 volumes of dichloromethane stirring at 25°C.Sodium bicarbonate was charged portion wise to the dichloromethane solution under stirring at 23°C +/- 2°C in about 10 minutes.N-acetyl-piperazine solution was loaded to dichlorometane-bicarbonate mixture under stirring at 300C +/- 2°C. The mixture was stirred at that temperature for 15 hours, monitoring the reaction by HPLC.The reaction mixture was cooled down at 23°C +/- 2°C.2 volumes of water were added under stirring at 25°C for about 15 minutes. Stirring was stopped and the phases were separated. Organic phases were separated.Organic phases were washed with water (2 x 2 volumes) under stirring for 15 minutes at 25°C. Water phases were collected and washed (2 x 3 volumes) with dichloromethane under stirring for 15 minutes at 25°C. Organic phases were removed, collected and dried over anhydrous sodium sulfate. The solid cake was washed with 2 volumes of dichloromethaneDichloromethane solution was concentrated (about 15 volumes at 400C under vacuum), subsequently 6 volumes of ethyl acetate were added.6 volumes of solvent were removed at 65°C.The solution was cooled down to 53°C in about 1 hour under slow stirring, then to 5°C +/- 2°C in about 2.5 hours under slow stirring to obtain crystallization of the material.The mixture was filtered at 5°C and the solid cake washed with 1 volume of ethyl acetate (cooled at 5°C).A second crop of material could be obtained from mother liquors by concentration and cooling. <n="15"/>The solid was dried in vacuo in oven (30°C+/-2°C) for about 15 hours.Average yield 70percent (wt) starting from methyl-4-bromo-methylbenzoate, average purity for this step (> 97percent) on 13 batches.
81%
Stage #1: With diisobutylaluminium hydride In hexane; dichloromethane at -78 - 20℃; for 16 h;
Stage #2: With water; Rochelle's salt In hexane; dichloromethane
Preparation 36[4-(Bromomethyl)phenyl]methanolTo a solution of 4-bromomethyl-benzoic acid methyl ester (5 g, 21.82 mmol) in DCM (200 mL) is added DIBAL-H (1.0 M in hexane, 54.56 mL, 54.56 mmol) drop wise at -78° C. The reaction mixture is allowed to warm to room temperature and stirred for 16 hours. The reaction mixture is quenched with sodium potassium tartrate (10percent solution, 8 mL) and diluted with DCM (100 mL). The combined organic layer is washed with water (50 mL), brine (25 mL), dried over sodium sulfate, and evaporated to give the title compound as an off white solid (3.5 g, 81percent). 1H NMR (400 MHz, CDCl3) δ 7.23-7.21 (m, 2H), 7.4-7.3 (m, 2H), 4.5-4.3 (bs, 2H), 4.68 (s, 2H).
80% With diisobutylaluminium hydride In dichloromethane at -78℃; for 1.5 h; Inert atmosphere To a solution of methyl 4-(bromomethyl)benzoate (2.3 g, 0.01 mol) in dry DCM (80 mL) was added DIBAL- H (22 mL, 0.03 mol) at -78 °C under N2. The mixture was stirred at -78 °C for 1.5 h. The reaction mixture was quenched by careful addition of H2O (50 mL), and then extracted with DCM (100 mL X 3). The combined organic layers were dried over anhydrous sodium sulfate and concentrated to afford (4- (bromomethyl)phe

Reference: [1] Patent: US6506770, 2003, B1,
[2] Patent: US6872714, 2005, B1,
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 3, p. 1250 - 1260
[4] European Journal of Medicinal Chemistry, 2015, vol. 104, p. 127 - 138
[5] Journal of Labelled Compounds and Radiopharmaceuticals, 2017, vol. 60, # 10, p. 466 - 480
[6] Patent: WO2008/125518, 2008, A2, . Location in patent: Page/Page column 12-14
[7] Patent: US2011/92531, 2011, A1, . Location in patent: Page/Page column 11
[8] Organic Letters, 2003, vol. 5, # 13, p. 2239 - 2242
[9] Patent: WO2015/103317, 2015, A1, . Location in patent: Page/Page column 196
[10] Tetrahedron, 1990, vol. 46, # 23, p. 7793 - 7802
[11] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 9, p. 3187 - 3200
[12] Patent: US2016/24063, 2016, A1, . Location in patent: Paragraph 0247-0249
[13] European Journal of Medicinal Chemistry, 2017, vol. 139, p. 290 - 304
  • 14
  • [ 2417-72-3 ]
  • [ 71831-21-5 ]
YieldReaction ConditionsOperation in experiment
58.3% With diisobutylaluminium hydride In methanol; hexane; water; ethyl acetate; toluene Preparation of 4-(bromomethyl)benzaldehyde
In a 5 lier three-neck flask under a nitrogen atmosphere methyl 4-(bromomethyl)benzoate (49.86 g, 217.7 mmol) was dissolved in 700 ml of toluene.
The stirring solution was cooled via dry ice/acetone bath to an internal temperature of -78° C. before the dropwise addition of diisobutylaluminum hydride (600 ml of a 1.0M solution in toluene).
The DIBAH was added at such a rate that the internal temperature never exceeded -70° C.
The progress of the reaction was monitored by thin layer chromatography (silica; 10percent ethyl acetate in hexane).
To the stirring reaction mixture was slowly added 250 ml of methanol.
The reaction mixture was then removed from the ice bath and allowed to warm to room temperature.
To this reaction mixture was then added water (500 ml), sodium potassium tartrate tetrahydrate (280 g) and ether (1.5 L) and the reaction was stirred at room temperature overnight.
The phases were then separated and the aqueous fraction was extracted with ether (750 ml).
The combined organic phases were washed with water (300 ml), followed by a wash with brine (300 ml) and then dried over magnesium sulfate.
The solvents were removed in vacuo to yield 41.6 grams of white solid which was then dissolved in hot ether and then filtered.
The ether filtrate was concentrated to about 250 ml on a steam bath and then solwly diluted with hexane to a final volume of about 350 ml.
After another filtration, the filtrate was permitted to cool to room temperature.
The crystals which formed during the cooling period were collected and dried to yield 25.5 g (58.3percent) of 4-bromomethylbenzyl alcohol as a crystalline solid.
Reference: [1] Patent: US5747517, 1998, A,
[2] Patent: US5747517, 1998, A,
  • 15
  • [ 2417-72-3 ]
  • [ 62642-62-0 ]
Reference: [1] Patent: WO2018/29604, 2018, A1,
  • 16
  • [ 2417-72-3 ]
  • [ 88089-94-5 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 46, p. 8049 - 8053
[2] Journal of Chemical Research, Miniprint, 1995, # 11, p. 2569 - 2583
  • 17
  • [ 99-75-2 ]
  • [ 2417-72-3 ]
  • [ 104901-43-1 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1986, vol. 22, p. 24 - 32[2] Zhurnal Organicheskoi Khimii, 1986, vol. 22, # 1, p. 30 - 39
  • 18
  • [ 2417-72-3 ]
  • [ 106261-48-7 ]
Reference: [1] Patent: WO2014/102376, 2014, A1,
[2] Patent: WO2014/102377, 2014, A1,
[3] Patent: WO2008/107368, 2008, A1,
  • 19
  • [ 109-01-3 ]
  • [ 2417-72-3 ]
  • [ 106261-48-7 ]
Reference: [1] Patent: WO2018/29604, 2018, A1,
  • 20
  • [ 110-85-0 ]
  • [ 2417-72-3 ]
  • [ 86620-81-7 ]
Reference: [1] Patent: WO2006/113468, 2006, A2, . Location in patent: Page/Page column 78
[2] European Journal of Medicinal Chemistry, 2016, vol. 109, p. 124 - 133
  • 21
  • [ 2417-72-3 ]
  • [ 142-64-3 ]
  • [ 142-63-2 ]
  • [ 86620-81-7 ]
Reference: [1] Patent: US4616086, 1986, A,
  • 22
  • [ 2417-72-3 ]
  • [ 86620-81-7 ]
Reference: [1] Patent: WO2016/146220, 2016, A1,
  • 23
  • [ 2417-72-3 ]
  • [ 333986-70-2 ]
Reference: [1] Patent: US6562978, 2003, B1,
  • 24
  • [ 2417-72-3 ]
  • [ 90-02-8 ]
  • [ 351335-29-0 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate; sodium iodide In N,N-dimethyl-formamide at 80℃; for 0.166667 h; Microwave irradiation General procedure: A microwave vial was charged with bromomethylbenzene derivative (0.4 mmol, 1 equiv), appropriated phenol derivative (0.44 mmol, 1.1 equiv), K2C03 (0.8 mmol, 2equiv), few crystals of Nal and dimethylformamide (DMF) (1 .4 mL). The reaction mixture was heatedunder microwave irradiation at 80°C for 10 minutes. Then, resulted mixture was poured into water and extracted with ethyl acetate. Combined organic phases were washed with brine, dried over Mg504 and concentrated under vacuum. The residue was purified by column chromatography on silica gel (CH2CI2/MeOH)
Reference: [1] Patent: WO2018/50771, 2018, A1, . Location in patent: Page/Page column 16; 33
[2] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 2, p. 239 - 243
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2417-72-3 ]

Aryls

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.90

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.90

Chemical Structure| 6515-58-8

[ 6515-58-8 ]

3-(Bromomethyl)benzoic acid

Similarity: 0.89

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.88

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.88

Bromides

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.90

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.90

Chemical Structure| 6515-58-8

[ 6515-58-8 ]

3-(Bromomethyl)benzoic acid

Similarity: 0.89

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.88

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.88

Esters

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.90

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.90

Chemical Structure| 78471-43-9

[ 78471-43-9 ]

Methyl 4-bromo-2-bromomethylbenzoate

Similarity: 0.88

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.88

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.88

Benzyl Bromides

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.90

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.90

Chemical Structure| 6515-58-8

[ 6515-58-8 ]

3-(Bromomethyl)benzoic acid

Similarity: 0.89

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.88

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.88